It has been years before visiting and i cannot believe what i am reading. Post after post talking about Cancer, MMD, HARS, ALS, ROP, FOB/FOP, huge revenues coming from Italy... and hundreds and hundreds of recs and five stars... Never seen something quite like this. Guys you are being taken to the cleaners by some sinister characters here. The reality is things still have to pan out, chances are slim and nothing is a slam duck. Then in case you haven�t noticed, the Street does not give a damn at this particular moment in time about bio firms. That does not help. Have known this company and Allan for quite a while, he is doing fine thank you, and i sincerely doubt we will see the pps above $1 in the next few months (and yes, i know all about data to be released and "announced" FOB partner before EOY). My bet is a 5:1 reverse split before EOY to avoid delisting. It has already been mentioned. Good luck to all.
I agree that that would be an impossible Price to stop but that price is what no one wants to pay.Whats even more amazing is that TRCA would have to pay 1/2 that for both indications so they deem it a big risk (2 trials).
Ive accepted a loss here and will use the tax loss write off in Dec
YOU can't believe what you're reading. Ha! This post is a joke. ALS revenues and its growth in Italy is fact. Italian legislative proposal to buy all Italian ALS patients IPLEX is fact. MMD and HARS PIII enabling trials starting buy EOY is fact. ROP study with IPLEX at Harvard is fact. 2 million+ warrants just bought in May to buy at exercise price of $1.10 is fact and those vest 11/07. No need for reverse split unless sp not over $1 for 10 days before 6/08 is fact. You're a lying basher is fact. Now you too are on ignore is fact.